Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
University of Oslo School of Pharmacy |
---|---|
Information provided by: | University of Oslo School of Pharmacy |
ClinicalTrials.gov Identifier: | NCT00244530 |
To compare renal function (51Cr-EDTA clearance) 48 hours post open-heart surgery (coronary bypass or valve surgery) in patients with impaired renal function after randomization to either nifedipine infusion at start of surgery and the following 24 hours or placebo (0.9% saline infusion). Study hypothesis is that nifedipine has a prophylactic effect on decline in renal function.
Condition | Intervention | Phase |
---|---|---|
Kidney Failure, Chronic Coronary Artery Disease |
Drug: Nifedipine |
Phase IV |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Open Label, Placebo Control, Parallel Assignment, Efficacy Study |
Official Title: | Postoperative Renal Function After Open-Heart Surgery in Patients With Impaired Renal Function Preoperatively. A Study of the Calcium Channel Blocker Nifedipine's Prophylactic Effect on Further Decline in Renal Function. |
Estimated Enrollment: | 20 |
Study Start Date: | June 2001 |
Estimated Study Completion Date: | October 2005 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Norway | |
Rikshospitalet University Hospital | |
Oslo, Norway, 0027 |
Study Chair: | Jan F Bugge, MD, PhD | Rikshospitalet University Hospital, Oslo, Norway |
Study ID Numbers: | NIF-123 |
Study First Received: | October 25, 2005 |
Last Updated: | December 20, 2006 |
ClinicalTrials.gov Identifier: | NCT00244530 History of Changes |
Health Authority: | Norway: Directorate for Health and Social Affairs |
Preventive Therapy Calcium Channel Blockers Kidney Failure, Chronic Coronary Artery Bypass Heart Valve Prosthesis Implantation |
Arterial Occlusive Diseases Vasodilator Agents Renal Insufficiency Heart Diseases Myocardial Ischemia Kidney Failure, Chronic Vascular Diseases Calcium Channel Blockers Cardiovascular Agents Ischemia |
Arteriosclerosis Nifedipine Coronary Disease Calcium, Dietary Urologic Diseases Renal Insufficiency, Chronic Kidney Diseases Coronary Artery Disease Kidney Failure |
Renal Insufficiency Vasodilator Agents Molecular Mechanisms of Pharmacological Action Myocardial Ischemia Physiological Effects of Drugs Kidney Failure, Chronic Calcium Channel Blockers Arteriosclerosis Reproductive Control Agents Nifedipine Membrane Transport Modulators Urologic Diseases Tocolytic Agents |
Therapeutic Uses Cardiovascular Diseases Kidney Diseases Arterial Occlusive Diseases Heart Diseases Vascular Diseases Cardiovascular Agents Pharmacologic Actions Coronary Disease Renal Insufficiency, Chronic Coronary Artery Disease Kidney Failure |